Company Filing History:
11 out of 41 
1 out of 1 
1 out of 1 
Years Active: 1990-2008
Title: The Innovations of Peter Michael Lansdorp
Introduction
Peter Michael Lansdorp is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 15 patents to his name, Lansdorp has established himself as a key figure in the development of advanced methodologies for immunological assays.
Latest Patents
Among his latest patents, Lansdorp has developed a method for creating tetrameric antibody complexes that block non-specific labeling of antigens. This method is crucial for preventing or inhibiting non-specific binding reactions between detection reagents and antigens in immunological assays. The tetrameric complexes consist of two monoclonal antibodies from one animal species linked to two monoclonal antibodies from another species, effectively reducing the binding of detection antibodies with Fc receptors on cell surfaces. Another notable patent involves a method for separating cells using immunorosettes. This technique allows for the formation of immunorosettes between nucleated cells and red blood cells, utilizing an antibody composition that may include bifunctional antibodies or tetrameric antibody complexes.
Career Highlights
Lansdorp has worked with several notable companies in the biotechnology sector, including Stemcell Technologies Inc. and Magnetix Biotechnology, Inc. His work in these organizations has contributed to advancements in cell separation and immunological detection methods.
Collaborations
Throughout his career, Lansdorp has collaborated with esteemed colleagues such as Terry Thomas and Carrie E Peters. These partnerships have further enhanced his research and development efforts in the field of immunology.
Conclusion
Peter Michael Lansdorp's innovative contributions to immunology through his patents and collaborations have significantly advanced the field. His work continues to influence the development of new methodologies for immunological assays and cell separation techniques.